ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TERN Terns Pharmaceuticals Inc

7.7825
-0.3475 (-4.27%)
Last Updated: 12:47:35
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Terns Pharmaceuticals Inc TERN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.3475 -4.27% 7.7825 12:47:35
Open Price Low Price High Price Close Price Prev Close
8.11 7.7825 8.2666 8.13
more quote information »

Recent News

Date Time Source Heading
2/26/20249:07IHNWFeatured1847 Holdings Engages Spartan Capital to Pursue Spinoff or Strategic Transaction for 1847 Cabinets Inc.
2/15/202418:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
2/14/202408:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/07/202416:20EDGAR2Form 8-K - Current report
2/07/202416:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New Chief..
2/07/202408:05GLOBETerns Pharmaceuticals Appoints Amy Burroughs as Chief..
2/02/202416:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
1/25/202419:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:05GLOBETerns Pharmaceuticals to Highlight 2024 Priorities and..
1/03/202416:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
11/29/202316:05GLOBETerns Pharmaceuticals to Present at the JMP Securities..
11/27/202316:05GLOBETerns Pharmaceuticals Mourns the Loss of Senthil Sundaram,..
11/14/202308:05GLOBETerns Pharmaceuticals Reports Third Quarter 2023 Financial..
11/13/202308:05GLOBETerns Pharmaceuticals Presents Late-Breaking Data from Phase..
11/09/202308:05GLOBETerns Pharmaceuticals to Participate in Upcoming November..
11/03/202316:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
11/02/202316:05GLOBETerns Pharmaceuticals Announces First Participant Dosed in..
10/19/202316:05GLOBETerns Pharmaceuticals to Participate in Upcoming Investor..
10/16/202308:05GLOBETerns Pharmaceuticals Announces Global Phase 1 Clinical..
10/10/202316:33EDGAR2Form 8-K - Current report
10/03/202316:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
9/06/202316:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
9/05/202316:05GLOBETerns Pharmaceuticals to Participate in Upcoming September..
8/08/202316:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202316:24EDGAR2Form 8-K - Current report
8/08/202316:15GLOBETerns Pharmaceuticals Reports Second Quarter 2023 Financial..
8/08/202316:05GLOBETerns Achieves Primary Endpoint and All Secondary Endpoints..
8/03/202318:00GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
8/03/202317:22EDGAR2Form 8-K - Current report
8/03/202317:05GLOBETerns Pharmaceuticals Announces Leadership Transition
7/18/202316:05GLOBETerns Pharmaceuticals to Host Virtual Key Opinion Leader..
7/05/202316:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
6/26/202316:05GLOBETerns Pharmaceuticals Highlights New Preclinical Data for..
6/06/202316:30GLOBETerns Pharmaceuticals to Present at Goldman Sachs 44th..
6/02/202316:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
5/25/202317:05GLOBETerns Pharmaceuticals Announces Publication of TERN-701..
5/24/202316:05GLOBETerns Pharmaceuticals to Present at Upcoming Investor..
5/22/202316:05GLOBETerns Pharmaceuticals to Highlight New Preclinical Data for..
5/15/202308:05GLOBETerns Pharmaceuticals Reports First Quarter 2023 Financial..
5/09/202316:05GLOBETerns Pharmaceuticals to Participate in the JMP Securities..
5/03/202316:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
3/27/202316:05GLOBETerns Pharmaceuticals Reports Fourth Quarter and Full Year..
3/27/202308:05GLOBETerns Pharmaceuticals Appoints Emil Kuriakose, M.D., as..
3/02/202316:05GLOBETerns Pharmaceuticals Provides Program Updates and Announces..

Your Recent History

Delayed Upgrade Clock